Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: Experiences and preliminary recommendations from the european childhood lymphoma pathology panel

American Journal of Surgical Pathology

Volumn 35, Issue 6, 2011, Pages 836-844

  Oschlies, Ilske ^a   Burkhardt, Birgit ^b   Chassagne Clement, Catherine ^c   D'Amore, Emanuel S ^d   Hansson, Ulrika ^e   Hebeda, Konnie ^f   Mc Carthy, Keith ^g   Kodet, Roman ^h   Maldyk, Jadwiga ⁱ   Müllauer, Leonhard ^j   Porwit, Anna ^k   Schmatz, Ana Iris ^l   Tinguely, Marianne ^m   Abramov, Dimitry ^a   Wotherspoon, Andrew ⁿ   Zimmermann, Martin ^b   Reiter, Alfred ^b   Klapper, Wolfram ^a,o  

^a UNIVERSITY OF KIEL   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c CENTRE LÉON BÉRARD   (France)

^d SAN BORTOLO HOSPITAL   (Italy)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g Department of Pathology   (United Kingdom)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ Department of Pathology   (Poland)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^m UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁿ ROYAL MARSDEN HOSPITAL   (United Kingdom)

^o UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

more..

Author keywords

ALL; B LBL; CD34; lymphoblastic; MPAL; precursor; T LBL; TdT

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CELL LINEAGE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUROPE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; METABOLISM; METHODOLOGY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EUROPE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PRACTICE GUIDELINES AS TOPIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79957997363     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318213e90e     Document Type: Article

References (29)

1. Bene MC. Biphenotypic, bilineal, ambiguous or mixed lineage: strange leukemias!. Haematologica. 2009;94:891-893.
2. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9:1783-1786.
3. Bernd HW, Krokowski M, Feller AC, et al. Expression of terminal desoxynucleotidyl transferase in Merkel cell carcinomas. Histopathology. 2007;50:676-678. (Pubitemid 46495817)
4. Browne P, Petrosyan K, Hernandez A, et al. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am J Clin Pathol. 2003;120:767-777. (Pubitemid 37339686)
5. Buresh CJ, Oliai BR, Miller RT. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall. Am J Clin Pathol. 2008;129:894-898.
6. Burkhardt B. Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases? Br J Haematol. 2010;149:653-668.
7. Cobaleda C, Schebesta A, Delogu A, et al. Pax5: the guardian of B cell identity and function. Nat Immunol. 2007;8:463-470. (Pubitemid 46605911)
8. Feller AC, Parwaresch MR, Stein H, et al. Immunophenotyping of T-lymphoblastic lymphoma/leukemia: correlation with normal T-cell maturation. Leuk Res. 1986;10:1025-1031. (Pubitemid 16015413)
9. Gerr H, Zimmermann M, Schrappe M, et al. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol. 2010;149:84-92.
10. Kansal R, Deeb G, Barcos M, et al. Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients. Am J Clin Pathol. 2004;121:512-525. (Pubitemid 38392959)
11. Martinez-Delgado B, Melendez B, Cuadros M, et al. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res. 2004;10:4971-4982. (Pubitemid 39099770)
12. McKenna RW, Asplund SL, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry. Leuk Lymphoma. 2004;45:277-285. (Pubitemid 38181429)
13. Morgenstern DA, Hasan F, Gibson S, et al. PAX5 expression in nonhematopoietic tissues: reappraisal of previous studies. Am J Clin Pathol. 2010;133:407-415.
14. Mullighan CG, Downing JR. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia. 2009;23:1209-1218.
15. Nasr MR, Rosenthal N, Syrbu S. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre- B-cell marker. Am J Clin Pathol. 2010;133:41-48.
16. Perkins SL. Work-up and diagnosis of pediatric non-Hodgkin's lymphomas. Pediatr Dev Pathol. 2000;3:374-390. (Pubitemid 30421952)
17. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535-1548.
18. Raetz EA, Perkins SL, Bhojwani D, et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer. 2006;47:130-140. (Pubitemid 44025244)
19. Reiter A. Diagnosis and treatment of childhood non-hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2007:285-296.
20. Res P, Spits H. Developmental stages in the human thymus. Semin Immunol. 1999;11:39-46. (Pubitemid 29083982)
21. Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM .90. German-Austrian-Swiss ALL-BFM Study Group. Blood. 2000;95:3310-3322. (Pubitemid 30428458)
22. Smock KJ, Nelson M, Tripp SR, et al. Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008;51:489-494.
23. Sullivan LM, Atkins KA, LeGallo RD. PAX immunoreactivity identifies alveolar rhabdomyosarcoma. Am J Surg Pathol. 2009;33:775-780.
24. Sur M, AlArdati H, Ross C, et al. TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis. Mod Pathol. 2007;20:1113-1120. (Pubitemid 47609060)
25. Swerdlow SH. Lymphomas: Epidemiologic, biologic, and pathogenetic features. In: Collins DC, Swerdlow SH, eds. Pediatric Hematopathology. New York, Edinburg, London, Philadelphia: Curchill Livingstone; 2001:199-210.
26. Swerdlow SH, Campo E, Harris N, et al.WHO Classification of Tumors of the Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008.
27. van Grotel M, van den Heuvel-Eibrink MM, van Wering ER, et al. CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51:737-740.
28. Vitale A, Guarini A, Ariola C, et al. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. Blood. 2006;107:473-479. (Pubitemid 43076367)
29. Xu XQ, Wang JM, Lu SQ, et al. Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica. 2009;94:919-927.